Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?
Garmpis N, Damaskos C, Garmpi A, Spartalis E, Kalampokas E, Kalampokas T, Margonis GA, Schizas D, Andreatos N, Angelou A, Lavaris A, Athanasiou A, Apostolou KG, Spartalis M, Damaskou Z, Daskalopoulou A, Diamantis E, Tsivelekas K, Alavanos A, Valsami S, Moschos MM, Sampani A, Nonni A, Antoniou EA, Mantas D, Tsourouflis G, Markatos K, Kontzoglou K, Perrea D, Nikiteas N, Kostakis A, Dimitroulis D.
Garmpis N, et al. Among authors: schizas d.
Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):950-960. doi: 10.26355/eurrev_201802_14376.
Eur Rev Med Pharmacol Sci. 2018.
PMID: 29509243
Review.